StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics cash

Cash and short-term investments held at the end of each period.

XORTX Therapeutics's cash was C$18.85M at Dec 31, 2021. For fiscal 2021 it was C$18.85M, up 10906.7% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2021Dec 31, 2021C$18.85M+10906.7%
FY2020Dec 31, 2020C$171.27K+192.2%
FY2019Dec 31, 2019C$58.61K-77.5%
FY2018Dec 31, 2018C$260.02K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021C$18.85M–
Q4 FY2020Dec 31, 2020C$171.27K–
Q4 FY2019Dec 31, 2019C$58.61K–
Q4 FY2018Dec 31, 2018C$260.02K–

More XORTX Therapeutics figures

See a number that looks wrong?